{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:47:18Z","timestamp":1790506038846,"version":"4.1.0"},"reference-count":199,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007364","name":"Fondazione CRT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2018.00550","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T09:27:00Z","timestamp":1543224420000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":72,"title":["The NOTCH Pathway and Its Mutations in Mature B Cell Malignancies"],"prefix":"10.3389","volume":"8","author":[{"given":"Francesca","family":"Arruga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Vaisitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Deaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1146\/annurev-immunol-020711-075027","article-title":"Pathogenesis of human B cell lymphomas","volume":"30","author":"Shaffer","year":"2012","journal-title":"Ann Rev Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/joim.12608","article-title":"Early stages in the ontogeny of small B-cell lymphomas: genetics and microenvironment","volume":"282","author":"Ghia","year":"2017","journal-title":"J Intern Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","article-title":"The canonical Notch signaling pathway: unfolding the activation mechanism","volume":"137","author":"Kopan","year":"2009","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S1044-5323(03)00008-3","article-title":"Regulation of B cell development by Notch\/RBP-J signaling","volume":"15","author":"Tanigaki","year":"2003","journal-title":"Semin Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1146\/annurev-pathol-052016-100127","article-title":"The varied roles of Notch in cancer","volume":"12","author":"Aster","year":"2017","journal-title":"Ann Rev Pathol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/978-3-319-89512-3_18","article-title":"Notch in Leukemia","volume":"1066","author":"McCarter","year":"2018","journal-title":"Adv Exp Med Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e67306","DOI":"10.1371\/journal.pone.0067306","article-title":"Gauging NOTCH1 activation in cancer using immunohistochemistry","volume":"8","author":"Kluk","year":"2013","journal-title":"PLoS ONE"},{"key":"B9","doi-asserted-by":"publisher","first-page":"26826","DOI":"10.18632\/oncotarget.5025","article-title":"Notch signaling deregulation in multiple myeloma: a rational molecular target","volume":"6","author":"Colombo","year":"2015","journal-title":"Oncotarget"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1242\/dev.063610","article-title":"Notch signaling: simplicity in design, versatility in function","volume":"138","author":"Andersson","year":"2011","journal-title":"Development"},{"key":"B11","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrm2009","article-title":"Notch signalling: a simple pathway becomes complex","volume":"7","author":"Bray","year":"2006","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"11785","DOI":"10.1074\/jbc.M708424200","article-title":"Localization of the delta-like-1-binding site in human Notch-1 and its modulation by calcium affinity","volume":"283","author":"Cordle","year":"2008","journal-title":"J Biol Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1242\/jcs.035683","article-title":"The molecular logic of Notch signaling\u2013a structural and biochemical perspective","volume":"121","author":"Gordon","year":"2008","journal-title":"J Cell Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0070-2153(10)92004-8","article-title":"Roles of glycosylation in Notch signaling","volume":"92","author":"Stanley","year":"2010","journal-title":"Curr Topics Dev Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/35019553","article-title":"Fringe differentially modulates Jagged1 and Delta1 signalling through Notch1 and Notch2","volume":"2","author":"Hicks","year":"2000","journal-title":"Nat Cell Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1097-2765(00)80417-7","article-title":"A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE","volume":"5","author":"Brou","year":"2000","journal-title":"Mol Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.devcel.2015.05.004","article-title":"Mechanical allostery: evidence for a force requirement in the proteolytic activation of Notch","volume":"33","author":"Gordon","year":"2015","journal-title":"Dev Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/30756","article-title":"Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain","volume":"393","author":"Schroeter","year":"1998","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/19091","article-title":"Presenilin is required for activity and nuclear access of Notch in Drosophila","volume":"398","author":"Struhl","year":"1999","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1126\/science.7725102","article-title":"Masking of the CBF1\/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2","volume":"268","author":"Hsieh","year":"1995","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","first-page":"10379","DOI":"10.1128\/MCB.25.23.10379-10390.2005","article-title":"RBP-Jkappa\/SHARP recruits CtIP\/CtBP corepressors to silence Notch target genes","volume":"25","author":"Oswald","year":"2005","journal-title":"Mol Cell Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1101\/gad.211912.112","article-title":"Dynamic binding of RBPJ is determined by Notch signaling status","volume":"27","author":"Castel","year":"2013","journal-title":"Genes Dev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/82644","article-title":"MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors","volume":"26","author":"Wu","year":"2000","journal-title":"Nat Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"7761","DOI":"10.1128\/MCB.21.22.7761-7774.2001","article-title":"p300 acts as a transcriptional coactivator for mammalian Notch-1","volume":"21","author":"Oswald","year":"2001","journal-title":"Mol Cell Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.molcel.2012.08.022","article-title":"NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function","volume":"48","author":"Yatim","year":"2012","journal-title":"Mol Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1007\/s00018-009-8668-7","article-title":"The Notch signaling pathway: transcriptional regulation at Notch target genes","volume":"66","author":"Borggrefe","year":"2009","journal-title":"Cell Mol Life Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ng0598-74","article-title":"Human deltex is a conserved regulator of Notch signalling","volume":"19","author":"Matsuno","year":"1998","journal-title":"Nat Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.devcel.2008.12.009","article-title":"Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis","volume":"16","author":"Phng","year":"2009","journal-title":"Dev Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"34371","DOI":"10.1074\/jbc.M101343200","article-title":"Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor","volume":"276","author":"Gupta-Rossi","year":"2001","journal-title":"J Biol Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"35847","DOI":"10.1074\/jbc.M103992200","article-title":"The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog","volume":"276","author":"Oberg","year":"2001","journal-title":"J Biol Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.molcel.2004.10.014","article-title":"Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover","volume":"16","author":"Fryer","year":"2004","journal-title":"Mol Cell"},{"key":"B32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1074-7613(00)80105-3","article-title":"Notch1 expression in early lymphopoiesis influences B versus T lineage determination","volume":"11","author":"Pui","year":"1999","journal-title":"Immunity"},{"key":"B33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3389\/fimmu.2014.00535","article-title":"B1b cells recognize protective antigens after natural infection and vaccination","volume":"5","author":"Cunningham","year":"2014","journal-title":"Front Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/icb.2009.73","article-title":"The role of notch signaling in the development of a normal B-cell repertoire","volume":"88","author":"Cruickshank","year":"2010","journal-title":"Immunol Cell Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1038\/sj.leu.2401942","article-title":"Notch-1 and Notch-2 exhibit unique patterns of expression in human B-lineage cells","volume":"14","author":"Bertrand","year":"2000","journal-title":"Leukemia"},{"key":"B36","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S1074-7613(03)00111-0","article-title":"Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development","volume":"18","author":"Saito","year":"2003","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.immuni.2004.05.001","article-title":"Cellular niches controlling B lymphocyte behavior within bone marrow during development","volume":"20","author":"Tokoyoda","year":"2004","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1074-7613(01)00185-6","article-title":"The earliest stages of B cell development require a chemokine stromal cell-derived factor\/pre-B cell growth-stimulating factor","volume":"15","author":"Egawa","year":"2001","journal-title":"Immunity"},{"key":"B39","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nri3445","article-title":"Regulation of innate and adaptive immunity by Notch","volume":"13","author":"Radtke","year":"2013","journal-title":"Nat Rev Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/ni1453","article-title":"Regulation of lymphocyte development by Notch signaling","volume":"8","author":"Tanigaki","year":"2007","journal-title":"Nat Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/ni793","article-title":"Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells","volume":"3","author":"Tanigaki","year":"2002","journal-title":"Nat Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.immuni.2008.12.016","article-title":"Lunatic and manic fringe cooperatively enhance marginal zone B cell precursor competition for delta-like 1 in splenic endothelial niches","volume":"30","author":"Tan","year":"2009","journal-title":"Immunity"},{"key":"B43","doi-asserted-by":"publisher","first-page":"232","DOI":"10.4049\/jimmunol.1402421","article-title":"Lunatic, manic, and radical fringe each promote T and B cell development","volume":"196","author":"Song","year":"2016","journal-title":"J Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.1073\/pnas.0811632106","article-title":"A differentiation pathway for B1 cells in adult bone marrow","volume":"106","author":"Esplin","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.4049\/jimmunol.171.6.2783","article-title":"Notch2 haploinsufficiency results in diminished B1 B cells and a severe reduction in marginal zone B cells","volume":"171","author":"Witt","year":"2003","journal-title":"J Immunol."},{"key":"B46","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.1128\/MCB.23.23.8637-8650.2003","article-title":"Activated Notch2 potentiates CD8 lineage maturation and promotes the selective development of B1 B cells","volume":"23","author":"Witt","year":"2003","journal-title":"Mol Cell Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"15454","DOI":"10.1073\/pnas.0702891104","article-title":"Notch1 engagement by Delta-like-1 promotes differentiation of B lymphocytes to antibody-secreting cells","volume":"104","author":"Santos","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1182\/blood-2006-09-046698","article-title":"Notch activity synergizes with B-cell-receptor and CD40 signaling to enhance B-cell activation","volume":"109","author":"Thomas","year":"2007","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/ajh.23979","article-title":"Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment","volume":"90","author":"Hallek","year":"2015","journal-title":"Am J Hematol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S0140-6736(08)60456-0","article-title":"Chronic lymphocytic leukaemia","volume":"371","author":"Dighiero","year":"2008","journal-title":"Lancet"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1182\/blood-2010-07-155663","article-title":"Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities","volume":"117","author":"Chiorazzi","year":"2011","journal-title":"Blood"},{"key":"B52","doi-asserted-by":"publisher","first-page":"16096","DOI":"10.1038\/nrdp.2016.96","article-title":"Chronic lymphocytic leukaemia","volume":"3","author":"Kipps","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B53","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1182\/blood-2008-02-139725","article-title":"Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells","volume":"113","author":"Rosati","year":"2009","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","first-page":"E2911","DOI":"10.1073\/pnas.1702564114","article-title":"Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia","volume":"114","author":"Fabbri","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.3324\/haematol.2014.117705","article-title":"Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation","volume":"100","author":"Onaindia","year":"2015","journal-title":"Haematologica"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1038\/bcj.2012.17","article-title":"Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy","volume":"2","author":"Nwabo","year":"2012","journal-title":"Blood Cancer J."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/leu.2013.319","article-title":"Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia","volume":"28","author":"Arruga","year":"2014","journal-title":"Leukemia"},{"key":"B58","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/leu.2017.296","article-title":"NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-kappaB pathways","volume":"32","author":"Benedetti","year":"2018","journal-title":"Leukemia"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1038\/leu.2017.90","article-title":"NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components","volume":"31","author":"Pozzo","year":"2017","journal-title":"Leukemia"},{"key":"B60","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1182\/blood-2014-10-607036","article-title":"Stromal cell-mediated glycolytic switch in CLL cells involves Notch-c-Myc signaling","volume":"125","author":"Jitschin","year":"2015","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1084\/jem.20110921","article-title":"Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation","volume":"208","author":"Fabbri","year":"2011","journal-title":"J Exp Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1365-2141.2009.07816.x","article-title":"A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation","volume":"146","author":"Di","year":"2009","journal-title":"Br J Haematol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.3109\/10428194.2012.749405","article-title":"A novel NOTCH1 PEST domain mutation in a case of chronic lymphocytic leukemia","volume":"54","author":"Sportoletti","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"B65","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature14666","article-title":"Non-coding recurrent mutations in chronic lymphocytic leukaemia","volume":"526","author":"Puente","year":"2015","journal-title":"Nature"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1038\/leu.2016.383","article-title":"Mutations in NOTCH1 PEST domain orchestrate CCL19-driven homing of chronic lymphocytic leukemia cells by modulating the tumor suppressor gene DUSP22","volume":"31","author":"Arruga","year":"2017","journal-title":"Leukemia"},{"key":"B67","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/leu.2012.357","article-title":"NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome","volume":"27","author":"Villamor","year":"2013","journal-title":"Leukemia"},{"key":"B69","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/leu.2014.143","article-title":"The gamma-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells","volume":"29","author":"Lopez-Guerra","year":"2015","journal-title":"Leukemia"},{"key":"B70","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1182\/blood-2014-01-546150","article-title":"Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial","volume":"123","author":"Stilgenbauer","year":"2014","journal-title":"Blood"},{"key":"B71","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/leu.2015.182","article-title":"NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation","volume":"30","author":"Pozzo","year":"2016","journal-title":"Leukemia"},{"key":"B72","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/leu.2017.291","article-title":"Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia","volume":"32","author":"Nadeu","year":"2018","journal-title":"Leukemia"},{"key":"B73","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/bjh.12800","article-title":"High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications","volume":"165","author":"Lionetti","year":"2014","journal-title":"Br J Haematol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/leu.2016.172","article-title":"Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome","volume":"31","author":"Barrio","year":"2017","journal-title":"Leukemia"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1158\/2159-8290.CD-14-0104","article-title":"Acquired initiating mutations in early hematopoietic cells of CLL patients","volume":"4","author":"Damm","year":"2014","journal-title":"Cancer Discov."},{"key":"B76","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13045-017-0450-y","article-title":"Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia","volume":"10","author":"Quijada-Alamo","year":"2017","journal-title":"J Hematol Oncol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1158\/1078-0432.CCR-13-0138","article-title":"Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia","volume":"19","author":"Ouillette","year":"2013","journal-title":"Clin Cancer Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.3324\/haematol.2015.136051","article-title":"Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia","volume":"101","author":"Rasi","year":"2016","journal-title":"Haematologica"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1182\/blood-2015-07-659144","article-title":"Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia","volume":"127","author":"Nadeu","year":"2016","journal-title":"Blood"},{"key":"B80","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.leukres.2008.09.016","article-title":"Notch and BCR signaling synergistically promote the proliferation of Raji B-lymphoma cells","volume":"33","author":"He","year":"2009","journal-title":"Leuk Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.leukres.2008.10.002","article-title":"Burkitt lymphoma translocation turns Notch over to the dark side","volume":"33","author":"Mirandola","year":"2009","journal-title":"Leuk Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.leukres.2006.05.003","article-title":"Establishment of a novel B-cell lymphoma cell line with suppressed growth by gamma-secretase inhibitors","volume":"30","author":"Tohda","year":"2006","journal-title":"Leuk Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/j.1349-7006.2009.01130.x","article-title":"Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma","volume":"100","author":"Lee","year":"2009","journal-title":"Cancer Sci"},{"key":"B84","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1182\/blood-2003-07-2340","article-title":"Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines","volume":"103","author":"Nefedova","year":"2004","journal-title":"Blood"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1182\/blood-2007-07-102632","article-title":"Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy","volume":"111","author":"Nefedova","year":"2008","journal-title":"Blood"},{"key":"B86","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.critrevonc.2010.09.003","article-title":"Mantle cell lymphoma: the promise of new treatment options","volume":"80","author":"Goy","year":"2011","journal-title":"Crit Rev Oncol Hematol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1200\/JCO.2008.16.8435","article-title":"Improvement of overall survival in advanced stage mantle cell lymphoma","volume":"27","author":"Herrmann","year":"2009","journal-title":"J Clin Oncol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1200\/JCO.2008.19.6121","article-title":"Outcome of deferred initial therapy in mantle-cell lymphoma","volume":"27","author":"Martin","year":"2009","journal-title":"J Clin Oncol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.semcancer.2011.09.007","article-title":"The complex landscape of genetic alterations in mantle cell lymphoma","volume":"21","author":"Royo","year":"2011","journal-title":"Semin Cancer Biol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1172\/JCI61272","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"122","author":"Jares","year":"2012","journal-title":"J Clin Invest."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1073\/pnas.0510441103","article-title":"Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma","volume":"103","author":"Greiner","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B92","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1182\/blood-2010-01-263806","article-title":"Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling","volume":"116","author":"Hartmann","year":"2010","journal-title":"Blood"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1182\/blood-2011-11-391474","article-title":"Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma","volume":"119","author":"Kridel","year":"2012","journal-title":"Blood"},{"key":"B94","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.celrep.2017.09.066","article-title":"A B cell regulome links Notch to downstream oncogenic pathways in small B cell lymphomas","volume":"21","author":"Ryan","year":"2017","journal-title":"Cell Rep."},{"key":"B95","doi-asserted-by":"publisher","first-page":"18250","DOI":"10.1073\/pnas.1314608110","article-title":"Landscape of somatic mutations and clonal evolution in mantle cell lymphoma","volume":"110","author":"Bea","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1182\/blood-2012-03-415380","article-title":"Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas","volume":"120","author":"Victora","year":"2012","journal-title":"Blood"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1182\/blood-2015-06-649905","article-title":"Cell of origin of transformed follicular lymphoma","volume":"126","author":"Kridel","year":"2015","journal-title":"Blood"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3324\/haematol.2012.082412","article-title":"Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma","volume":"98","author":"Bachy","year":"2013","journal-title":"Haematologica"},{"key":"B99","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/leu.2014.251","article-title":"Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry study","volume":"29","author":"Junlen","year":"2015","journal-title":"Leukemia"},{"key":"B100","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1200\/JCO.2012.48.3990","article-title":"Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa\/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource","volume":"31","author":"Link","year":"2013","journal-title":"J Clin Oncol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1586\/ehm.09.49","article-title":"Biology and treatment of follicular lymphoma","volume":"2","author":"Piccaluga","year":"2009","journal-title":"Expert Rev Hematol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1172\/JCI63186","article-title":"Pathogenesis of follicular lymphoma","volume":"122","author":"Kridel","year":"2012","journal-title":"J Clin Invest."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1182\/blood-2012-09-457283","article-title":"Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma","volume":"121","author":"Green","year":"2013","journal-title":"Blood"},{"key":"B104","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet."},{"key":"B105","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep."},{"key":"B106","doi-asserted-by":"publisher","first-page":"E1116","DOI":"10.1073\/pnas.1501199112","article-title":"Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation","volume":"112","author":"Green","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B107","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/ng.3473","article-title":"Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma","volume":"48","author":"Okosun","year":"2016","journal-title":"Nat Genet."},{"key":"B108","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/joim.12633","article-title":"Genetic landscape and deregulated pathways in B-cell lymphoid malignancies","volume":"282","author":"Rosenquist","year":"2017","journal-title":"J Intern Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/nm.3940","article-title":"Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1172\/JCI85795","article-title":"Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma","volume":"126","author":"Cardenas","year":"2016","journal-title":"J Clin Invest."},{"key":"B112","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1158\/2159-8290.CD-16-0975","article-title":"CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas","volume":"7","author":"Jiang","year":"2017","journal-title":"Cancer Discov."},{"key":"B113","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/path.4428","article-title":"Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours","volume":"234","author":"Karube","year":"2014","journal-title":"J Pathol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development","volume":"209","author":"Rossi","year":"2012","journal-title":"J Exp Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1182\/blood-2016-07-729954","article-title":"Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma","volume":"129","author":"Krysiak","year":"2017","journal-title":"Blood"},{"key":"B116","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/ni1075","article-title":"Delta-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo","volume":"5","author":"Hozumi","year":"2004","journal-title":"Nat Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1182\/blood-2004-02-0514","article-title":"Mastermind critically regulates Notch-mediated lymphoid cell fate decisions","volume":"104","author":"Maillard","year":"2004","journal-title":"Blood"},{"key":"B118","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1158\/2159-8290.CD-16-1189","article-title":"BCL6 Antagonizes NOTCH2 to maintain survival of human follicular lymphoma cells","volume":"7","author":"Valls","year":"2017","journal-title":"Cancer Discov."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1038\/onc.2010.544","article-title":"High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas","volume":"30","author":"Kochert","year":"2011","journal-title":"Oncogene"},{"key":"B120","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1182\/blood-2010-01-265827","article-title":"Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed\/Sternberg cells","volume":"116","author":"Stanelle","year":"2010","journal-title":"Blood"},{"key":"B121","doi-asserted-by":"publisher","first-page":"236","DOI":"10.2174\/156652411795243423","article-title":"Notch and NF-\u03baB signaling pathways in the biology of classical Hodgkin lymphoma","volume":"11","author":"Schwarzer","year":"2011","journal-title":"Curr Mol Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ccr.2014.02.005","article-title":"Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance","volume":"25","author":"Cao","year":"2014","journal-title":"Cancer Cell"},{"key":"B123","volume-title":"WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"B124","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/nrclinonc.2013.197","article-title":"Diffuse large B-cell lymphoma-treatment approaches in the molecular era","volume":"11","author":"Roschewski","year":"2014","journal-title":"Nat Rev Clin Oncol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nri3814","article-title":"Germinal centres and B cell lymphomagenesis","volume":"15","author":"Basso","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"B127","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet."},{"key":"B129","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1182\/blood-2013-02-483727","article-title":"Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing","volume":"122","author":"Morin","year":"2013","journal-title":"Blood"},{"key":"B131","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1053\/j.seminhematol.2015.01.005","article-title":"The genetic landscape of diffuse large B-cell lymphoma","volume":"52","author":"Pasqualucci","year":"2015","journal-title":"Semin Hematol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/gcc.22328","article-title":"Whole exome sequencing of relapsed\/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma","volume":"55","author":"Mareschal","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"B133","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1158\/1078-0432.CCR-15-2123","article-title":"Genetic landscapes of relapsed and refractory diffuse large B-cell lymphomas","volume":"22","author":"Morin","year":"2016","journal-title":"Clin Cancer Res."},{"key":"B134","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med."},{"key":"B136","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1242\/jcs.073924","article-title":"Serum- and glucocorticoid-inducible kinase 1 (SGK1) controls Notch1 signaling by downregulation of protein stability through Fbw7 ubiquitin ligase","volume":"124","author":"Mo","year":"2011","journal-title":"J Cell Sci."},{"key":"B137","doi-asserted-by":"publisher","first-page":"e37111","DOI":"10.1371\/journal.pone.0037111","article-title":"Phosphorylation of nicastrin by SGK1 leads to its degradation through lysosomal and proteasomal pathways","volume":"7","author":"Mo","year":"2012","journal-title":"PLoS ONE"},{"key":"B138","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/leu.2017.251","article-title":"Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets","volume":"32","author":"Karube","year":"2018","journal-title":"Leukemia"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/hon.880","article-title":"Richter syndrome: molecular insights and clinical perspectives","volume":"27","author":"Rossi","year":"2009","journal-title":"Hematol Oncol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1182\/blood-2010-09-302174","article-title":"The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation","volume":"117","author":"Rossi","year":"2011","journal-title":"Blood"},{"key":"B141","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1200\/JCO.2005.05.0187","article-title":"Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation","volume":"24","author":"Tsimberidou","year":"2006","journal-title":"J Clin Oncol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1200\/JCO.2007.11.8513","article-title":"Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia","volume":"26","author":"Tsimberidou","year":"2008","journal-title":"J Clin Oncol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1084\/jem.20131448","article-title":"Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome","volume":"210","author":"Fabbri","year":"2013","journal-title":"J Exp Med."},{"key":"B144","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s11899-014-0223-4","article-title":"Risk factors for Richter syndrome in chronic lymphocytic leukemia","volume":"9","author":"Parikh","year":"2014","journal-title":"Curr Hematol Malig Rep."},{"key":"B145","doi-asserted-by":"publisher","first-page":"18261","DOI":"10.1073\/pnas.0606108103","article-title":"NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth","volume":"103","author":"Palomero","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B146","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1158\/0008-5472.CAN-17-4004","article-title":"Novel richter syndrome xenograft models to study genetic architecture, biology, and therapy responses","volume":"78","author":"Vaisitti","year":"2018","journal-title":"Cancer Res."},{"key":"B147","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1365-2141.2010.08482.x","article-title":"A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome","volume":"152","author":"Rasi","year":"2011","journal-title":"Br J Haematol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"5646","DOI":"10.1182\/blood-2008-01-129726","article-title":"CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome?","volume":"111","author":"Aydin","year":"2008","journal-title":"Blood"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1182\/blood-2013-11-516229","article-title":"How we treat Richter syndrome","volume":"123","author":"Parikh","year":"2014","journal-title":"Blood"},{"key":"B150","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nri3383","article-title":"Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes","volume":"13","author":"Cerutti","year":"2013","journal-title":"Nat Rev Immunol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.beha.2016.07.002","article-title":"Epidemiology and environmental aspects of marginal zone lymphomas","volume":"30","author":"Sriskandarajah","year":"2017","journal-title":"Best Pract Res Clin Haematol."},{"key":"B152","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.V87.1.299.299","article-title":"Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features","volume":"87","author":"Dierlamm","year":"1996","journal-title":"Blood"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","article-title":"Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome","volume":"117","author":"Rinaldi","year":"2011","journal-title":"Blood"},{"key":"B154","doi-asserted-by":"publisher","first-page":"62627","DOI":"10.18632\/oncotarget.11548","article-title":"Recurrent mutations in NF-kappaB pathway components, KMT2D, and NOTCH1\/2 in ocular adnexal MALT-type marginal zone lymphomas","volume":"7","author":"Johansson","year":"2016","journal-title":"Oncotarget"},{"key":"B155","doi-asserted-by":"publisher","first-page":"17038","DOI":"10.18632\/oncotarget.14928","article-title":"The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP","volume":"8","author":"Jung","year":"2017","journal-title":"Oncotarget"},{"key":"B156","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/path.4933","article-title":"Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma","volume":"243","author":"Moody","year":"2017","journal-title":"J Pathol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3324\/haematol.11635","article-title":"NOTCH2 mutations in marginal zone lymphoma","volume":"93","author":"Troen","year":"2008","journal-title":"Haematologica"},{"key":"B158","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1182\/blood-2008-12-194852","article-title":"TNFAIP3\/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas","volume":"114","author":"Honma","year":"2009","journal-title":"Blood"},{"key":"B159","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.1182\/blood-2008-08-174110","article-title":"The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas","volume":"113","author":"Novak","year":"2009","journal-title":"Blood"},{"key":"B160","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1182\/blood-2011-06-359166","article-title":"Alteration of BIRC3 and multiple other NF-\u03baB pathway genes in splenic marginal zone lymphoma","volume":"118","author":"Rossi","year":"2011","journal-title":"Blood"},{"key":"B161","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/cncr.27773","article-title":"Survival of patients with marginal zone lymphoma: analysis of the surveillance, epidemiology, and end results database","volume":"119","author":"Olszewski","year":"2013","journal-title":"Cancer"},{"key":"B162","doi-asserted-by":"publisher","first-page":"5207","DOI":"10.1158\/1078-0432.CCR-14-0496","article-title":"Emerging role of infectious etiologies in the pathogenesis of marginal zone B-cell lymphomas","volume":"20","author":"Zucca","year":"2014","journal-title":"Clin Cancer Res."},{"key":"B163","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1182\/blood-2015-12-624304","article-title":"The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance","volume":"127","author":"Zucca","year":"2016","journal-title":"Blood"},{"key":"B164","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.beha.2016.09.004","article-title":"Molecular pathogenesis of splenic and nodal marginal zone lymphoma","volume":"30","author":"Spina","year":"2017","journal-title":"Best Pract Res Clin Haematol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1074-7613(03)00029-3","article-title":"Regulation of marginal zone B cell development by MINT, a suppressor of Notch\/RBP-J signaling pathway","volume":"18","author":"Kuroda","year":"2003","journal-title":"Immunity"},{"key":"B166","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4049\/jimmunol.179.1.195","article-title":"Synergism between NF-kappa B1\/p50 and Notch2 during the development of marginal zone B lymphocytes","volume":"179","author":"Moran","year":"2007","journal-title":"J Immunol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nri2656","article-title":"The follicular versus marginal zone B lymphocyte cell fate decision","volume":"9","author":"Pillai","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.1182\/blood-2010-12-325944","article-title":"CD19-independent instruction of murine marginal zone B-cell development by constitutive Notch2 signaling","volume":"118","author":"Hampel","year":"2011","journal-title":"Blood"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1084\/jem.20120910","article-title":"Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma","volume":"209","author":"Kiel","year":"2012","journal-title":"J Exp Med."},{"key":"B170","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1182\/blood-2015-11-624312","article-title":"Splenic marginal zone lymphoma: from genetics to management","volume":"127","author":"Arcaini","year":"2016","journal-title":"Blood"},{"key":"B171","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia","volume":"365","author":"Wang","year":"2011","journal-title":"N Engl J Med."},{"key":"B172","doi-asserted-by":"publisher","first-page":"e83244","DOI":"10.1371\/journal.pone.0083244","article-title":"Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma","volume":"8","author":"Parry","year":"2013","journal-title":"PLoS ONE"},{"key":"B173","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/leu.2013.365","article-title":"Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation","volume":"28","author":"Martinez","year":"2014","journal-title":"Leukemia"},{"key":"B174","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","article-title":"Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing","volume":"21","author":"Parry","year":"2015","journal-title":"Clin Cancer Res."},{"key":"B175","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bbaexp.2005.02.001","article-title":"The C terminus of MINT forms homodimers and abrogates MINT-mediated transcriptional repression","volume":"1729","author":"Li","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"B176","doi-asserted-by":"publisher","first-page":"14892","DOI":"10.1074\/jbc.M110.181156","article-title":"Transcriptional repression in the Notch pathway: thermodynamic characterization of CSL-MINT (Msx2-interacting nuclear target protein) complexes","volume":"286","author":"VanderWielen","year":"2011","journal-title":"J Biol Chem."},{"key":"B177","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S1074-7613(02)00271-6","article-title":"Deltex1 redirects lymphoid progenitors to the B cell lineage by antagonizing Notch1","volume":"16","author":"Izon","year":"2002","journal-title":"Immunity"},{"key":"B178","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/MOH.0b013e3283477815","article-title":"Non-MALT marginal zone lymphoma","volume":"18","author":"Thieblemont","year":"2011","journal-title":"Curr Opin Hematol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1182\/blood-2016-02-696757","article-title":"The genetics of nodal marginal zone lymphoma","volume":"128","author":"Spina","year":"2016","journal-title":"Blood"},{"key":"B180","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Engl J Med."},{"key":"B181","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N Engl J Med."},{"key":"B182","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1172\/JCI61188","article-title":"Molecular pathogenesis of multiple myeloma and its premalignant precursor","volume":"122","author":"Kuehl","year":"2012","journal-title":"J Clin Invest."},{"key":"B183","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrc3257","article-title":"The genetic architecture of multiple myeloma","volume":"12","author":"Morgan","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B184","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2013.12.015","article-title":"Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy","volume":"25","author":"Lohr","year":"2014","journal-title":"Cancer Cell"},{"key":"B185","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1182\/blood-2003-07-2254","article-title":"Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells","volume":"103","author":"Jundt","year":"2004","journal-title":"Blood"},{"key":"B186","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1016\/j.humpath.2010.05.002","article-title":"Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"41","author":"Skrtic","year":"2010","journal-title":"Hum Pathol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/leu.2013.6","article-title":"Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes","volume":"27","author":"Colombo","year":"2013","journal-title":"Leukemia"},{"key":"B188","doi-asserted-by":"publisher","first-page":"56013","DOI":"10.18632\/oncotarget.10820","article-title":"Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche","volume":"7","author":"Colombo","year":"2016","journal-title":"Oncotarget"},{"key":"B189","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1182\/blood-2005-08-3329","article-title":"Recent insights into the role of Notch signaling in tumorigenesis","volume":"107","author":"Leong","year":"2006","journal-title":"Blood"},{"key":"B190","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/leu.2013.27","article-title":"Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4\/SDF-1","volume":"27","author":"Mirandola","year":"2013","journal-title":"Leukemia"},{"key":"B191","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/S0002-9440(10)62491-1","article-title":"Skeletrophin, a novel ubiquitin ligase to the intracellular region of Jagged-2, is aberrantly expressed in multiple myeloma","volume":"166","author":"Takeuchi","year":"2005","journal-title":"Am J Pathol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.1158\/0008-5472.CAN-08-3467","article-title":"Loss of the SMRT\/NCoR2 corepressor correlates with JAG2 overexpression in multiple myeloma","volume":"69","author":"Ghoshal","year":"2009","journal-title":"Cancer Res."},{"key":"B193","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.exphem.2008.08.006","article-title":"Identification of primary MAFB target genes in multiple myeloma","volume":"37","author":"van","year":"2009","journal-title":"Exp Hematol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.semcdb.2012.01.016","article-title":"Therapeutic approaches to modulating Notch signaling: current challenges and future prospects","volume":"23","author":"Groth","year":"2012","journal-title":"Semin Cell Dev Biol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/nature08878","article-title":"Therapeutic antibody targeting of individual Notch receptors","volume":"464","author":"Wu","year":"2010","journal-title":"Nature"},{"key":"B196","doi-asserted-by":"publisher","first-page":"8046","DOI":"10.1074\/jbc.M800170200","article-title":"Modulation of Notch signaling by antibodies specific for the extracellular negative regulatory region of NOTCH3","volume":"283","author":"Li","year":"2008","journal-title":"J Biol Chem."},{"key":"B197","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.stem.2009.05.019","article-title":"DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency","volume":"5","author":"Hoey","year":"2009","journal-title":"Cell Stem Cell"},{"key":"B198","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature08543","article-title":"Direct inhibition of the NOTCH transcription factor complex","volume":"462","author":"Moellering","year":"2009","journal-title":"Nature"},{"key":"B199","doi-asserted-by":"publisher","first-page":"59235","DOI":"10.18632\/oncotarget.19494","article-title":"The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells","volume":"8","author":"Secchiero","year":"2017","journal-title":"Oncotarget"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00550\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T02:02:23Z","timestamp":1573005743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00550\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":199,"alternative-id":["10.3389\/fonc.2018.00550"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2018.00550","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,26]]},"article-number":"550"}}